Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Topics in Behavioral Neurosciences|August 17, 2017
Oxytocin and Anxiety DisordersMichael G Gottschalk, Katharina Domschke
Dialogues in Clinical Neuroscience|September 5, 2017
Genetics of generalized anxiety disorder and related traitsMichael G Gottschalk, Katharina Domschke
Current Opinion in Psychiatry|November 18, 2015
Novel developments in genetic and epigenetic mechanisms of anxietyMichael G Gottschalk, Katharina Domschke
The International Journal of Neuropsychopharmacology|December 25, 2014
Targeted multiplexed selected reaction monitoring analysis evaluates protein expression changes of molecular risk factors for major psychiatric disordersHendrik Wesseling, Michael G Gottschalk, Sabine Bahn
Frontiers in Psychiatry|April 9, 2020
Epigenetics Underlying Susceptibility and Resilience Relating to Daily Life Stress, Work Stress, and Socioeconomic StatusMichael G Gottschalk, Katharina Domschke, Miriam A Schiele
Clinical Psychology Review|March 13, 2020
The applied implications of epigenetics in anxiety, affective and stress-related disorders - A review and synthesis on psychosocial stress, psychotherapy and preventionMiriam A Schiele, Michael G Gottschalk, Katharina Domschke
The International Journal of Neuropsychopharmacology|January 23, 2015
Proteomic enrichment analysis of psychotic and affective disorders reveals common signatures in presynaptic glutamatergic signaling and energy metabolismMichael G Gottschalk, Hendrik Wesseling, Paul C Guest, et al.
Biomarkers in Medicine|December 12, 2013
The use of proteomic biomarkers for improved diagnosis and stratification of schizophrenia patientsPaul C Guest, Man K Chan, Michael G Gottschalk, et al.
Schizophrenia Research|June 24, 2016
Proteomic systems evaluation of the molecular validity of preclinical psychosis models compared to schizophrenia brain pathologyDavid A Cox, Michael G Gottschalk, Hendrik Wesseling, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 23, 2017
Lithium reverses behavioral and axonal transport-related changes associated with ANK3 bipolar disorder gene disruptionMichael G Gottschalk, Melanie P Leussis, Tillmann Ruland, et al.
Pageof 2